APOE and Alzheimer disease: When examining the combined group of individuals with aMCI or dementia due to AD compared to cognitively unimpaired individuals, KL-VSHET carriers showed 41% lower odds of being classified within the cognitively impaired group (p = .205), with a stronger trend within APOE ε4 carriers.